UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
Impact of TNF on Oncolytic Virotherapy
Impact of TNF on Oncolytic Virotherapy is a funding opportunity from UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR, up to 438164, closing August 31, 2028.
Aug 31, 2028
(762d left)Overview
Project Summary: Oncolytic virotherapy (OV) represents a novel method to treat a variety of solid tumors by inducing anti-tumor immune responses. While this therapy has been extremely efficacious in a wide variety of preclinical models, translating these successes into human patients has proven challenging. It has…